BDSI News and Press, BioDelivery Sciences International Inc. From 02/20/22

Collegium Pharmaceutical has seen a decent 2021, but starts 2022 with a big and interesting deal. Investors are highly attracted to diversification and in anticipation of huge synergies. This looks compelling, yet the earnings situation will likely become complicated for quite a w...

NEW YORK, NY / ACCESSWIRE / February 17, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: US Ecology, Inc. (NASDAQ:ECOL)'s...

According to an article published by Bloomberg (1), the world may face a massive shortfall of what’s arguably the most critical metal for global economies: copper. The copper industry needs to spend upwards of $100 billion to close what could be an annual supply deficit of 4.7 million ...

Collegium Pharmaceutical is acquiring BioDelivery Sciences for $5.60 per share in an all cash offer. I argue why the deal is good, but not great for BioDelivery Sciences. We take a cursory look at Collegium Pharmaceutical. For further details see: BioDelivery Sciences Bu...

Worries about Ukraine and Federal Reserve policy led to an uncertain session on Monday, with the Dow and S&P 500 posting modest losses. The Nasdaq finished the day just below the unchanged mark. While the overall market failed to find significant buying interest, electric vehicle stocks m...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the biggest movers in today’s market is BioDelivery Sciences (NASDAQ: BDSI ). At the time of writing, BDSI stock has surged more than 50% higher on incredible volume. This move comes, as many would expec...

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) and BioDelivery Sciences International Inc. (NASDAQ: BDSI) have announced a definitive agreement where Collegium will acquire BDSI for USD 5.60 per share in cash.  BDSI holds a portfolio of pain and neurology products ...

Gainers: BioDelivery Sciences International (NASDAQ:BDSI) +52%. Knightscope (NASDAQ:KSCP) +31%. Ebang International (NASDAQ:EBON) +22%. Cornerstone Building Brands (NYSE:CNR) +22%. Kelly Services (NASDAQ:KELYA) +18%. NRx Pharmaceuticals (NASDAQ:NRXP) +17%. Cadiz (NASDAQ:CDZI) +...

Stocks weren't able to mount a convincing recovery on Monday morning after facing steep volatility toward the end of last week. As of 10 a.m. ET today, the Dow Jones Industrial Average (DJINDICES: ^DJI) was down 295 points to 34,443. The S&P 500 (SNPINDEX: ^GSPC) had los...

MONSEY, N.Y., Feb. 14, 2022 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of BioDelivery Sciences International, Inc. (Nasdaq: BDSI) (“BDSI”) acted in the best interests of BDSI shareholders in approving the sale of BDSI to ...